Puma Biotech: Fourth Quarter Earnings Overview

Puma Biotechnology Announces Fourth Quarter Financial Results

Puma Biotechnology Inc., headquartered in Los Angeles, revealed a net profit of $13.4 million for its fourth quarter.

The company reported earnings of $0.26 per share, with adjusted earnings—excluding stock option costs—coming in at $0.29 per share.

During this period, Puma Biotechnology generated $75.5 million in revenue.

Looking at the full year, the company achieved a total profit of $31.1 million, or $0.61 per share, with annual revenue reaching $228.4 million.

For the first quarter ending in March, Puma Biotechnology anticipates revenue between $38 million and $42 million.

Projected revenue for the entire year is expected to fall within the range of $214 million to $221 million.